B. Braun, which owns shares in Germany-based hospital operator Rhoen-Klinikum is upping its stake in Rhoen to 25 percent in efforts to prevent a buyout of Rhoen by B. Braun rival Fresenius.
The move closely follows last year’s efforts, which saw B. Braun acquire five percent in Rhoen to prevent Fresenius’s agenda of becoming the nation’s largest private hospital operator. B. Braun and Fresenius are rivals in the healthcare equipment market.
Both B. Braun and hospital operator Asklepios – which also holds shares in Rhoen – were reportedly concerned that a buyout by Fresenius would reduce competition in the market. In a statement released Tuesday, B. Braun said it “remains committed to sustainably secure the minority shareholding position” in Rhoen.
The acquisition remains subject to regulatory approval.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Massachusetts AG Sues Insulin Makers and PBMs Over Alleged Price-Fixing Scheme
Jan 14, 2025 by
CPI
Apple and Amazon Avoid Mass Lawsuit in UK Over Alleged Collusion
Jan 14, 2025 by
CPI
Top Agent Network Drops Antitrust Suit Against National Association of Realtors
Jan 14, 2025 by
CPI
Weil, Gotshal & Manges Strengthens Antitrust Practice with New Partner
Jan 14, 2025 by
CPI
Russian Court Imposes Hefty Fine on Google for Non-Compliance with Content Removal Orders
Jan 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand